These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1696737)

  • 1. Interferons in renal-cell carcinoma: status and prospects.
    De Mulder PH; Debruyne FM; Beniers AJ
    Prog Clin Biol Res; 1990; 348():49-59. PubMed ID: 1696737
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon-alpha and interleukin-2 in the treatment of renal cell cancer.
    Holdener EE; Emmons RP; Brunda M; Evans L; Levitt D
    Prog Clin Biol Res; 1990; 348():61-9. PubMed ID: 2201034
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant alpha-2 or gamma interferon in the treatment of metastatic renal cell carcinoma: results of two phase II/III trials.
    Otto U; Schneider AW; Conrad S; Klosterhalfen H
    Prog Clin Biol Res; 1990; 350():275-82. PubMed ID: 2117287
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant alpha-interferon plus vinblastine in metastatic renal-cell cancer: analysis of response and survival in 58 evaluable patients.
    Bergerat JP; Ford J; Herbrecht R; Dufour P; Oberling F; Jacqmin D; Bollack C; Prevot G; Salze P; Jurascheck F
    Prog Clin Biol Res; 1990; 348():137-50. PubMed ID: 2385604
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic interferon gamma application in patients with renal cell carcinoma.
    Grups JW; Frohmüller HG
    Prog Clin Biol Res; 1990; 350():257-62. PubMed ID: 2117285
    [No Abstract]   [Full Text] [Related]  

  • 6. New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical data.
    Debruyne FM; Franssen MP; Beniers AJ; Schalken JA; de Mulder PH
    Prog Clin Biol Res; 1990; 350():243-55. PubMed ID: 2117284
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-tumor effects of interleukin 2 against renal cell carcinoma. In vitro study and clinical application.
    Marumo K; Tazaki H
    Prog Clin Biol Res; 1990; 350():263-73. PubMed ID: 2117286
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer immunotherapy using tumor-infiltrating lymphocytes.
    Figlin RA
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):33-5. PubMed ID: 1535456
    [No Abstract]   [Full Text] [Related]  

  • 9. Is cytotoxic chemotherapy effective in the treatment of advanced renal cell carcinoma?
    Swanson DA
    Semin Urol; 1993 Feb; 11(1):35-40. PubMed ID: 7682003
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG; Kapoor A
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon in metastatic renal cell carcinoma.
    Fosså SD
    Semin Oncol; 2000 Apr; 27(2):187-93. PubMed ID: 10768597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options.
    Lam JS; Leppert JT; Belldegrun AS; Figlin RA
    BJU Int; 2005 Sep; 96(4):483-8. PubMed ID: 16104896
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferons and interleukins in metastatic renal cell carcinoma.
    Choudhury M; Efros M; Mittelman A
    Urology; 1993 Jan; 41(1 Suppl):67-72. PubMed ID: 7678365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we really making an advance in the treatment of metastatic renal cell carcinoma?
    Kirkali Z
    Eur Urol; 2006 Apr; 49(4):604-5. PubMed ID: 16481098
    [No Abstract]   [Full Text] [Related]  

  • 15. Limitations of surgical curability in renal cell carcinoma.
    Geboers AD; Debruyne FM
    Prog Clin Biol Res; 1992; 378():175-86. PubMed ID: 1301579
    [No Abstract]   [Full Text] [Related]  

  • 16. [The value of interferons, interleukin-2 and tumor necrosis factor in the therapy of renal cell cancer].
    Wirth M
    Urologe A; 1991 Mar; 30(2):77-80. PubMed ID: 1711729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy?
    Pantuck AJ; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):693s-696s. PubMed ID: 17255295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic options in renal cell carcinoma.
    Buzaid AC; Todd MB
    Semin Oncol; 1989 Feb; 16(1 Suppl 1):12-9. PubMed ID: 2465574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha interferon therapy for renal cell carcinoma: summary of four collaborative trials. Cancer Research Committee.
    Aso Y; Umeda T; Niijima T
    Prog Clin Biol Res; 1989; 303():653-9. PubMed ID: 2675017
    [No Abstract]   [Full Text] [Related]  

  • 20. [The medical treatment of renal cancer in adults].
    Sculier JP
    Rev Med Brux; 1989 May; 10(5):190-6. PubMed ID: 2662317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.